JPMorgan Chase & Co. (JPM) Receives a Rating Update From a Top Analyst
Genmab Upgraded at RBC on Valuation
Home Depot Analyst Ratings
DZ BANK AG Remains a Buy on JPMorgan Chase & Co. (JPM)
JPMorgan Chase Analyst Ratings
TD Cowen Remains a Buy on UnitedHealth (UNH)
Morgan Stanley Sticks to Their Buy Rating for JPMorgan Chase & Co. (JPM)
Buy Rating for Procter & Gamble: Sustained Competitive Advantage and Strong EPS Visibility
Stifel Adjusts Price Target on Home Depot to $380 From $374, Maintains Hold Rating
Hold Rating Maintained Amid Johnson & Johnson Acquisition and Foreign Exchange Concerns
Piper Sandler Adjusts Price Target on JPMorgan Chase & Co. to $230 From $220, Maintains Overweight Rating
UnitedHealth Buy Rating Affirmed Amidst Medicare Advantage Growth and Positive Sector Outlook
UBS Raises Price Target on Procter & Gamble to $191 From $183, Maintains Buy Rating
Goldman Sachs Keeps Their Buy Rating on JPMorgan Chase & Co. (JPM)
Stifel Nicolaus Remains a Hold on Johnson & Johnson (JNJ)
Broadcom Analyst Ratings
Merck & Co Analyst Ratings
Rosenblatt Adjusts Price Target on Broadcom to $2,400 From $1,650
Morgan Stanley Adjusts Price Target on Merck to $134 From $132
BMO Capital Adjusts Exxon Mobil's Price Target to $125 From $127, Keeps Market Perform Rating